Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
SETBP1 induces transcription of developmental genes
Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy
SETBP1 induces transcription of developmental genes ( Dr Rocco Piazza - University of Milano-Bicocca, Milan, Italy )
17 Jun 2018
Combination therapy for CLL in the CAPTIVATE trial
Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy
Combination therapy for CLL in the CAPTIVATE trial ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )
17 Jun 2018
Efficacy of novel agents in r/r T pro-lymphocytic leukaemia
Prof Philipp Staber - Medical University of Vienna, Vienna, Austria
Efficacy of novel agents in r/r T pro-lymphocytic leukaemia ( Prof Philipp Staber - Medical University of Vienna, Vienna, Austria )
17 Jun 2018
Isatuximab in combination to treat relapsed/refractory MM
Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma...
Isatuximab in combination to treat relapsed/refractory MM ( Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma Foundation )
17 Jun 2018
Venetoclax in patients with previously treated WM
Prof Jorge Castillo - Dana-Farber Cancer Institute, Boston, USA
Venetoclax in patients with previously treated WM ( Prof Jorge Castillo - Dana-Farber Cancer Institute, Boston, USA )
17 Jun 2018
Single cell profiling reveals key differences in architecture of stem and...
Dr Anindita Roy - University of Oxford, Oxford, UK
Single cell profiling reveals key differences in architecture of stem and progenitor cells throughout life ( Dr Anindita Roy - University of Oxford, Oxford, UK )
17 Jun 2018
ICLL07 FILO study: Minimal residual disease still detectable after first line...
Prof Pierre Feugier - University of Lorraine, Nancy, France
ICLL07 FILO study: Minimal residual disease still detectable after first line combination therapy ( Prof Pierre Feugier - University of Lorraine, Nancy, France )
17 Jun 2018
Even late progressors with high risk factors in PRIMA prognostic index are more...
Prof Marek Trněný - Charles University, Prague, Czech Republic
Even late progressors with high risk factors in PRIMA prognostic index are more likely to die ( Prof Marek Trněný - Charles University, Prague, Czech Republic )
17 Jun 2018
Patient relevant outcomes and advocacy
Jan Geissler - CML Advocates Network, EuroBloodNET ePAG
Patient relevant outcomes and advocacy ( Jan Geissler - CML Advocates Network, EuroBloodNET ePAG )
17 Jun 2018
The mutational landscape of AML
Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany
The mutational landscape of AML ( Prof Lars Bullinger - Charité University of Berlin, Berlin, Germany )
17 Jun 2018
Development of a risk stratifying prognostic index for ALL
Prof Anthony Moorman - Newcastle University, Newcastle, UK
Development of a risk stratifying prognostic index for ALL ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
17 Jun 2018
Specification of haematopoetic stem cell fate via modulation of mitochondrial...
Dr Mukul Girotra - Ludwig Center for Cancer Research, Lausanne, Switzerland
Specification of haematopoetic stem cell fate via modulation of mitochondrial activity ( Dr Mukul Girotra - Ludwig Center for Cancer Research, Lausanne, Switzerland )
17 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation